JAYSON DUFFIN: Open Payments
NPI 1730871633 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 28 payments from 12 companies in 2025. Trend: 2023 $105 · 2024 $1,626 · 2025 $599
Food & beverage: $509Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $139 |
| UCB, Inc. | 6 | $132 |
| ABBVIE INC. | 3 | $65 |
| Amgen Inc. | 4 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| Bioventus LLC | 2 | $31 |
| Smith+Nephew, Inc. | 1 | $25 |
| Fresenius Kabi USA, LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Genentech USA, Inc. | 1 | $18 |
Products named: TREMFYA, Bimzelx, SKYRIZI, ILARIS, EXOGEN ULTRASOUND BONE HEALING SYSTEM, ENBREL, Salto Talaris Total Ankle Prosthesis, BENLYSTA.
Industry payments across UT — which companies pay providers there.
